Sirona Capital
Finance · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
121 E 23rd St Apt 17B, New York City, Ne...Phone Number
+61 892121200Website
www.sironacapital.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
2
1
1
1
About Sirona Capital
Sirona Capital consults to a number of major global private equity funds, investment banks and institutional investors, in relation to identifying and evaluating investments in Australia. Our client's capital tends to be patient and long dated with a 5 to 6 year average investment term. Comprised of a team of highly experienced professionals who have held positions within leading local and international corporations, investment banks, corporate advisory and financial services firms; Sirona Capital has built an Australian business investing and advising across asset classes, capital structures and geographies: Fully established fund platform with an Australian Financial Services Licence 8 investment professionals, 3 operational and other professionals, with its office in the global natural resources hub of Perth Sirona Capital's unique combination of extensive financial and industry expertise and access to long dated capital allows us to provide valuable independent corporate advice andRead more
Sirona Capital Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sirona Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Sirona Capital
Check out if Sirona Capital is spiking on competitors!
Check if Sirona Capital has recently received funding, and reach out quickly before it becomes old news!
Sirona Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Sirona Capital had a recent Job posting/layoffs
Earning: See what the market has to say on Sirona Capital recently announced quarterly report
Product Launch: Get notified when Sirona Capital launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Sirona Capital has new funding data
Recommended Actions
Reach out to Masked Content who joined Sirona Capital as Masked Content
Find 3 more new buyers
Compare Similar Companies to Sirona Capital
Compare insights from companies similar to Sirona Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sirona Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Sirona Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Sirona Capital.
Sirona Capital financials insights
Gather financial insights about Sirona Capital, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Other Financing Round
$45M
Sirona Capital Tech Stack
A closer look at the technologies used by Sirona Capital
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Left Company
Executive Move
Greg Haskis, Chief Financial Officer, has left the organization and now serves as the Head of Finance at DUG Technology.
Project
Spending/Investment
Sirona Capital News & Media
CG Oncology Raises $120M in Series E Financing
CG Oncology, an Irvine, CA-based oncolytic immunotherapy company, raised $120M in Series E funding. The round was co-led by ORI Capital, Longitude Capital and Decheng Capital, with participation from RA Capital Management, Acorn Bioventures, Malin Corporation, Ally Bridge Group and Sirona Capital. In connection with the financing, Brian Liu, M.D., Principal from Longitude Capital, will join […] The post CG Oncology Raises $120M in Series E Financing appeared first on FinSMEs.
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sirona Capital
Sign Up For FreeTo access detailed company insights
Sirona Capital consults to a number of major global private equity funds, investment banks and institutional investors, in relation to identifying and evaluating investments in Australia. Our client's capital tends to be patient and long dated with a 5 to 6 year average investment term. Comprised of a team of highly experienced professionals who ha... Read More
